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Introduction
One in eight women (about 12.5%) in the United States will develop invasive breast
cancer over the course of her lifetime (U.S Breast Cancer Statistics, 2018). Not only is breast
cancer deadly, but it can spread to other parts of the body such as lymph nodes, lungs, and other
organs. Breast cancer cells in the lymph nodes suggest an increased risk of cancer metastasis and
decreased rate of survival. Breast cancer is treated in various ways, such as radiation and surgical
removal of the breast, which leaves the survivors with physical and emotional trauma.
Chemotherapy is another common treatment, but it has side effects such as hair loss, easy
bruising, bleeding, and cognitive disorders that can affect concentration and focus (American
Cancer Society, 2016). Due to these negative side effects, researchers have been looking for
supportive alternate treatments that are equally effective but lack the side effects. One possibility
is Cannabis-derived cannabinoid drugs. Cannabinoids are being investigated (Qamri et al., 2009)
as anticancer treatments with fewer side effects than conventional chemotherapy.
Purpose and Significance
Studies suggest that cannabinoids can kill cancer cells, and researchers have proposed
that the concentration of cannabinoids makes a difference in determining cancer cell apoptosis
(cell death); however, optimization of the cannabinoids concentration is necessary (Sarfaraz,
Adhami, Syned, Afaq, & Murkhtar, 2008). Sarfaraz et al. (2008) proposed that the
overexpression of cannabinoid receptors (CB1 and CB2: G-protein couple receptors located
throughout the body) may lead to cancer cell death, but little or no expression of these receptors
could lead to cell proliferation and metastasis, due to the suppression of the antitumor immune
response. It is unknown how the concentrations of two common cannabinoids—cannabidiol
(CBD) and ∆9 -tetrahydrocannabinol (THC)—affect cancer cells. Therefore, studying the effect
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of varying concentrations of CBD and THC on breast cancer cells could offer a potential avenue
for new treatments of this disease.
Because Cannabis is easily grown, the cost of cannabinoid-based cancer treatment could
potentially be much lower than other forms of chemotherapy (Gringsppoon, 1999). Furthermore,
cannabinoid drugs are known to reduce many side effects associated with other treatments, such
as pain, loss of appetite, nausea, and vomiting (Rocha, Stefano, Haiek, Oliveira & Da Silveria,
2008; Tramèr et al., 2001; Ware et al., 2010), which will benefit cancer patients by preventing
them from taking additional medications for side effects. The use of cannabinoid drugs can also
potentially void the need for traumatic surgeries. Lastly, when an effective concentration is
known for treatment, cannabinoids should work more efficiently than most other cancer
treatments because they inhibit the cancer growth without interfering with normal cells (Kogan,
2005). Not only are cannabinoid drugs affordable and have anti-proliferative properties, they can
also reduce side effects associated with other treatments, making them a potential treatment to
research and develop.
Review of Literature
Cancer Pathogenesis
During the cell cycle, there are checkpoints that are responsible for making sure the cell
is capable to function and regulate when necessary. At the checkpoint, if a cell has any damage
or cannot serve its purpose, the cell is marked for apoptosis. Apoptosis is a normal physiological
process that removes unwanted cells by programming the cell’s death. Some damaged cells
escape the checkpoint without being marked for apoptosis. These abnormal cells can grow out of
proportion and become cancer cells (Visconti et al., 2016).
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Cancer cells are cells that have lost the ability to function normally or die but can still
divide. Uncontrollable growth forms a mass of tissue called a tumor. Because cancer cells are
similar to normal cells, it is difficult to selectively kill them without affecting normal cells
(Yasukawa, 2014). When the cancer cells spread to different regions of the body, it is called
metastasis. Cyclin E is a cell cycle regulator and is important, together with cyclin-dependent
kinase (cdk) 2, for the G1/S transition during the cell cycle. In tumors, there is normally an
overexpression of the cyclin E protein, causing cell proliferation and bypassing the checkpoint
leading to cancer.
There are five types of cancer classified by their tissue/cell types of origin: sarcomas,
leukemia, lymphomas, melanoma, and carcinomas (Movva, 2015). Carcinomas, which were the
focus of this study, develop in the epithelial cells. They start from the skin or epithelial tissue and
spread to the internal organs, and they are caused by the damage of DNA resulting in a mutation
(Rosenbreg, 1987). MCF-7, which is a human breast adenocarcinoma cell line, was the selected
cell type utilized. Breast cancer is the most common cancer and the leading cause of cancer death
in American women. American Cancer Society estimated that 41,400 deaths occurred in 2018
among males and females due to breast cancer.
The method of cancer treatment is determined based on the cancer type, the stage of
cancer development, and the person’s health. The three common cancer treatments are radiation,
surgery, and chemotherapy. Radiation therapy uses high energy waves to make small breaks in
the DNA inside cancer cells. During this process, abnormal cells are destroyed and new, normal
cells replace the dead ones (Lawrence, Ten Haken & Giaccia, 2008). Surgery is used to remove a
tumor prior to metastasis, whereas chemotherapy uses drugs to inhibit cancer cell function (Ho
Im et al., 2016).
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Cannabinoids
Cannabinoids are compounds originally discovered in the plant Cannabis sativa. They
are potential chemotherapeutic agents being investigated to treat cancer. The discovery of
cannabinoids occurred in the 1940s, and the receptors for these molecules were discovered in the
mid-1980s (Pertwee, 2006). To date, approximately 113 cannabinoids have been isolated from
Cannabis (Namdar et al., 2018).
There are three primary types of cannabinoids: endocannabinoids, synthetic cannabinoids,
and phytocannabinoids (Qamri et al., 2009). Endocannabinoids are endogenous cannabinoids
that the human body synthesizes and releases; they also interact with the CB1 and CB2 receptors.
Anandamide is a type of endocannabinoid that binds to CB1 and activates the receptor (Pertwee,
2008). Synthetic cannabinoids are designed for research purposes, and they also interact with the
CB1 and CB2 receptors (Seely, Lapoint, Moran, & Fattore, 2012). Synthetic cannabinoids are
mildly psychoactive because of their cannabimimetic properties (Grigoryev et al., 2011).
Phytocannabiniods are cannabinoids that occur naturally in the Cannabis plant; the most
thoroughly investigated phytocannabinoids are THC and CBD (Figure 1) (Borgelt et al., 2013).
CBD has a significantly different action than THC (Gertsch, Pertwee & Di Marzo, 2010). THC
directly activates the CB1 receptor, which causes a change in brain function due to its
psychoactive properties. Unlike THC, CBD has a low affinity for the CB1/CB2 receptors.
However, it causes cellular modulation that leads to an indirect interaction with the CB1 receptor
(Pacher, Batkai, & Kunos, 2006). CBD induces endogenous neurotransmitter uptake, which is
responsible for signal transmission in the brain (Moreira et al., 2011).
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Figure 1. THC and CBD chemical structures.

Cannabinoids serve a purpose in pharmaceutical science, even though Cannabis is just
becoming accepted by society (Gupta, 2014). Due to powerful therapeutic properties used to
treat several medical conditions, cannabinoids have been contributing to pharmaceutical benefits
since 1850. Research has shown that cannabinoids can influence factors that help the body
respond to injury, defend against viruses and bacteria, and repair damaged tissues (Nagarkatti,
Pandey, Rieder, Hegde, & Nagarkatti, 2009). Cannabinoids can also regulate energy in the body
by activating the 5-hydroxytryptamine (serotonin) receptor, which contributes to the reduction of
addiction, anxiety, depression, nausea, pain, and vomiting as well as improves appetite and sleep
(Crippa et al., 2010).
CBD and THC inhibit cancer metastasis by activating the CB1 and CB2 receptors (Patsos,
Hicks, Greenhough, Williams, & Paraskeva, 2005). CB1 receptors are in the basal ganglia, brain,
cerebellum, limbic system, and reproductive system. CB2 receptors are correlated with antiinflammatory processes and are found in the spleen in addition to the locations mentioned for
CB1. CB2 is expressed on demand; the modulation of CB2 levels is a common feature to cells of
macrophage lineage as they participate in the inflammatory response and undergo differential
gene expression and acquisition of distinctive functional properties (Cabral, 2009).
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Cannabinoids and Cancer
The mechanism by which cannabinoids directly kill breast cancer cells is currently
unknown, but researchers have postulated a potential mechanism. Velasco et al. (2016)
suggested a pathway that cannabinoids might use to cause cancer cell apoptosis (Figure 2). THC
stimulates the stress-regulated protein pathway, which enhances the inhibitory interaction of the
pseudokinase homologue 3 with pro-survival kinases, Akt. This leads to inhibition of the
mammalian target of rapamycin complex 1 and the subsequent stimulation of autophagymediated cell death (Velasco et al., 2016).
Velasco et al. ( 2016) proposed the mechanism for glioma cancer cells. Even though the
mechanism for apoptosis in breast cancer cells is not known, most cancer apoptosis probably
follows a similar mechanism. Researchers have frequently determined that THC and CBD can
kill cancer cells. However, the specific concentration of CBD and THC is rarely addressed.
Sarfaraz et al. (2008) speculated that the concentration makes a difference in whether there will
be apoptosis or proliferation in cancer cells.
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Figure 2. The proposed mechanism of apoptosis caused by cannabinoids on glioma cells
(Velasco et al., 2016).

Sarfaraz et al. (2008) proposed that overexpressed CB1 and CB2 receptors may lead to
tumor destruction, but low or no expression of these receptors could lead to cell proliferation and
metastasis because of the suppression of the antitumor immune response. This suggests that
cannabinoids as an anticancer treatment will not exhibit the side effects associated with current
cancer treatments, making cannabinoids a promising contribution to current cancer therapies.
Because the concentration of cannabinoids affects cancer cells, the precise concentration of THC
and CBD needed to cause apoptosis of the breast cancer cells must be examined.
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Methods
This study was conducted at the University of Northern Colorado in the Department of
Chemistry and Biochemistry and the School of Biological Sciences. Cell culture was performed
with a MCF-7 human breast cancer cell line obtained from Bio-Rad (Bio Rad Laboratories,
Hercules, CA, USA). Cultures were kept in an incubator at 37 ºC with 95% humidified air and
5% CO2 . Two controls for this experiment were used: cells in Roswell Park Memorial Institute
(RPMI) culture medium without cannabinoids and cells in the same medium with ethanol. The
ethanol was added to determine the effect ethanol had on cancer cells, due to the fact that the
drugs were dissolved in ethanol. Two treatment groups were also used to compare CBD and
THC. These treatment groups were treated with CBD or THC at varying concentrations,
including 0.1, 1, 10, and 100 micromolar. These concentrations were arbitrarily chosen because
there is not an established baseline of concentrations that might affect the cancer cells. To study
whether CBD and THC cause apoptosis or proliferation in MCF-7 cells, an MTT assay was
performed to determine cell proliferation through a colorimetric measurement of metabolic
mitochondrial activity.
Media
Fresh media was made by adding either a mixture of fetal bovine and horse sera (FBE,
cat. No. VWR) or using an RPMI base. Additionally, penicillin 100 unit/L/streptomycin (100
ug/L (ThermoFisher, 10378016), sodium pyruvate 1 mM (ThermoFisher, 11360070), bovine
insulin 10 mg/mL (ThermoFisher, 12585014), L-glutamine 2 mM (ThermoFisher, 25030081),
Hepes (buffer agent) 10 mM (ThermoFisher, 15630080), and 2-mercaptoethanol 0.142 M
(ThermoFisher, 35602BID) were added to the RMPI to provide a complete media (cRPMI) with
everything the MCF-7 cancer cells need to grow.
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Cell Growth and Passing
After incubation for 24 hours (37 ℃, 95% humidified air, 5% CO2 ), old medium was
discarded and cells were trypsinized by adding 3 mL of trypsin (1x) concentration
(ThermoFisher, 25200-056) to the flask and incubating the flasks at 37 ºC and 5% CO2 for 1-2
min, until cells lifted from the culture flask surface. Six mL of fresh media were added to each
flask to neutralize the trypsin reaction. The cells, now in fresh media, were centrifuged at 1200
rpm in conical tubes for 5 min. Supernatant was discarded, and the cell pellets were resuspended
in 1 mL of fresh media each. A 10 µL sample of MCF-7 cells was stained with trypan blue (1:1)
and counted using a Countess II Automated Cell Counter. These results were used to determine
the cell density to determine the volume containing the proper number of cells needed to be
grown in each well. The calculated number of the cells were then resuspended in fresh media (12
mL in the T-75 flask), then transferred constantly to 96 wells plates and incubated until they
were 80% confluent (roughly 48-64 hr.).
Adding Cannabinoids to the Cancer Cell Cultures
The first control group was suspended in media without any cannabinoids or ethanol (the
vehicle control); the second control group was suspended in media with ethanol equal to the
amount of ethanol in which the cannabinoids were delivered. Each concentration treatment had
three replicates. For the first treatment of breast cancer cells, 0.1 µM CBD was added to each of
the three wells in the first column. The second column had 1 µM of CBD, while the third column
had 10 µM CBD, and lastly the fourth column had 100 µM of CBD. A second set of breast
cancer cells followed the same protocol with the concentrations of THC using a different plate.
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MTT Assay
The plates were incubated (37 ºC, 95% humidified air, 5% CO2 ) for 24 hours.
Tetrazolium dye-MTT assay (ThermoFisher, V13154) was added to the MCF-7 cancer cells to
measure cell metabolic activity and determine the actual percent of the MCF-7 cancer cell
apoptosis (Kowalczewska et al., 2016).
Western Blot
The protocol by Pullen et al. (2012) was used in determining cell viability through
Western blot. MCF-7 cells were analyzed for apoptosis through Western blotting by detecting
PARP cleavage. This allowed comparison of control group apoptosis (baseline) to cells treated
with cannabinoids and served as a preliminary measure of induction of apoptosis, which could be
the basis for later studies examining the timing of apoptosis. MCF-7 cells were treated with lysis
buffer (from Cell Signaling Technology, a detergent containing phosphatase and protease
inhibitors to preserve protein structure) (ThermoFisher, 89900) to obtain intracellular proteins;
immediately after lysis, samples were microcentrifuged for 5 min at 13,000xg. Proteins were
denatured and chemically reduced at 95-100 ºC in 1X Laemmli buffer containing βmercaptoethanol for 10 min, then cooled on ice. The supernatant was subjected to SDS-PAGE
with 4%-20% Tris-glycine polyacrylamide gels for resolution based on size (kDa), and it was
then electro-transferred to a nitrocellulose membrane. Twenty-five milliliters of 1X Tris-buffered
saline (TBS) were used to wash the nitrocellulose membrane for 5 min at room temperature.
Then, to block unspecific binding, the membrane was incubated at room temperature for 1 h in a
mixture of TBS with 5% (v/v) milk and 0.05% (v/v), (TBST). The membrane was then rinsed
with TBST and incubated with a primary antibody specific for detecting human poly (ADProbosyl) polymerase 1 at 1:1000) diluted in 1X TBST containing 5% bovine serum albumin
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(BSA), with gentle agitation overnight at 4 °C. The membrane was washed three times for 5 min
each with TBST. The membrane was then incubated for 45 min with anti-rabbit IgG conjugated
to horse radish peroxidase (HRP). TBST was used to wash the membrane, and detection was
made by using enhanced chemiluminescence substrate activated by HRP (PerkinElmer, Rodgau,
Germany). Densitometric analysis was performed using ImageJ software (National Institutes of
Health, Bethesda, MD, USA).
Statistical Analysis
An ANOVA was performed to compared cannabinoid concentrations among themselves
and with control to determine if there was a significant difference in percent of the breast cancer
cell death in both MTT assay and Western blot. Poc-host test was performed to determine which
effects due to concentrations differ from one another. The treatment groups were compared with
the control since the control was set as the standard.
Results
The first study determined the exact concentration of CBD and THC needed to kill MCF7 breast cancer cells. CBD was more effective at stimulating apoptosis compared to THC.
However, the most effective concentration of CBD varied between the MTT assay and the
Western blot assay. Since the THC was not as effective as we predicted, we could test the THC
in higher concentrations in the future to gauge effectiveness. Because these are preliminary
results, the assays will need to be replicated. This study will be replicated to determine if the
basic findings of the original work are accurate. Due to the therapeutic potential of CBD and
THC, the findings of this study could contribute to the ever-growing body of knowledge
regarding cancer treatments.
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MTT ASSAY
The MTT assay detects the proliferation of MCF-7 breast cancer cells. As the
proliferation increases, it indicates that the concentration causes stimulation of proliferation in
the MCF-7 breast cancer cells. The lower proliferation indicated that the MCF-7 breast cancer
cells were inhibited by the concentration of the CBD or THC. The media was the control, which
showed typical/expected proliferation of breast cancer cells. As illustrated in Figure 3, CBD is
the more effective inducer of apoptosis of the MCF-7 breast cancer cells compared to the THC
and the control. The CBD and THC concentrations at 100 µM were the most effective among the
concentrations.
However, THC concentrations had mixed effects on the MCF-7 breast cancer cells. At 10
µM, THC stimulated the cancer cell growth compared to media alone, and that is the opposite
effect hypothesized. Nevertheless, the rest of the THC concentrations had no effect on the
proliferation of the MCF-7 breast cancer cell.
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Figure 3. MCF-7 proliferation as a function of CBD and THC. The first bar of each
concentration is CBD (orange), and THC is the next bar of each concentration (blue).

Western Blot
The Western blot assessment illustrates the ratio between cleaved and uncleaved parp
protein. The ratio is directly proportional to the apoptosis of the MCF-7 breast cancer cells. The
higher ratio of the cleaved to uncleaved PARP protein indicates the apoptosis of the breast
cancer cells with influence by CBD or THC.
As illustrated in Figure 4, THC concentration caused more apoptosis in MCF-7 breast
cancer cells compared to CBD. However, CBD and THC concentration at 0.1 µM showed an
increase in the ratio of the cleaved and uncleaved PARP protein, indicating that there is an
apoptosis of breast cancer. A decrease in ratio shows no changes in MCF-7 breast cancer cells, or
perhaps stimulation occurs, leading to proliferation of the MCF-7 breast cancer cells. As
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illustrated in Figure 4, CBD concentrations of 1 µM and 100 µM decrease in the ratio, which
indicates a lack of apoptosis or perhaps a proliferation of the MCF-7 breast cancer cells.

CLeavged vc. Uncleaveged
PARP

1.4
1.2
1

0.8
0.6
0.4
0.2
0

media

ethanol

0.1 µM

1 µM

10 µM

100 µM

CBD and THC Concentration
Figure 4. Detection of Parp-protein cleavage. An increase in the bar graph, higher than the
media, indicates MCF-7 breast cancer cell apoptosis. CBD (orange), THC (blue), and the
Controls (green).

Statistical Analysis
ANOVA - MTT Assay
A t-test of CBD or THC to media shows no significant different; however, comparison of
each concentration to the media differs. The two-way analysis of variance is an extension of the
ANOVA that examines the influence of two different categorical independent variables on one
continuous dependent variable. The use of two-way ANOVA is to understand if there is an
interaction between the two independent variables, which in this case are CBD and THC, on the
dependent variable, which in this case is the apoptosis of the MCF-7 breast cancer cells shown in
Figure 5 and 6. The P-values need to be equal to or less than 0.0500 to account for statistical
significant differences between the variables.
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As illustrated in Table 1, the comparison of CBD and THC to media is P value = 0.0598,
which indicates that there is no statistical significance; however, there is a significant difference
between the concentrations. As illustrated in Table 2, each concentration, including the control, was
compared with all the concentrations to find a significant difference. All the concentrations show no
significant difference except for the relationship between 10 µM THC and 100 µM CBD, which
stipulates that at 100 µM CBD concentration, the concentration has an opposite effect on the MCF-7
breast cancer cells compared to all the other concentrations and the media.

Table 1: MTT assay comparison of CBD
and THC treatment to the media.
Significant difference is P valve of 0.05

ANOVA
P value
Exact or
approximate P value?
P value summary
Are means signif.
different? (P < 0.05)
Number of groups
Friedman statistic
Data summary
Number of
treatments (columns)
Number of subjects
(rows)

0.0597
Approximate
Ns
No
9
14.97

9
12
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Table 2: The mean significant at the 0.5 level. Multiple comparison of t-test of each group to every
other group. The difference is significant at the P-valve 0.05 level.
Dunn's multiple comparisons test
Control vs. 0.1 µM THC
Control vs. 1 µM THC
Control vs. 10 µM THC
Control vs. 100 µM THC
Control vs. 0.1 µM CBD
Control vs. 1 CBD
Control vs. 10 CBD
Control vs. 100 CBD
0.1 µM THC vs. 1 µM THC
0.1 µM THC vs. 10 µM THC
0.1 µM THC vs. 100 µM THC
0.1 µM THC vs. 0.1 µM CBD
0.1 µM THC vs. 1 CBD
0.1 µM THC vs. 10 CBD
0.1 µM THC vs. 100 CBD
1 µM THC vs. 10 µM THC
1 µM THC vs. 100 µM THC
1 µM THC vs. 0.1 µM CBD
1 µM THC vs. 1 CBD
1 µM THC vs. 10 CBD
1 µM THC vs. 100 CBD
10 µM THC vs. 100 µM THC
10 µM THC vs. 0.1 µM CBD
10 µM THC vs. 1 CBD
10 µM THC vs. 10 CBD
10 µM THC vs. 100 CBD
100 µM THC vs. 0.1 µM CBD
100 µM THC vs. 1 CBD
100 µM THC vs. 10 CBD
100 µM THC vs. 100 CBD
0.1 µM CBD vs. 1 CBD
0.1 µM CBD vs. 10 CBD
0.1 µM CBD vs. 100 CBD
1 CBD vs. 10 CBD
1 CBD vs. 100 CBD
10 CBD vs. 100 CBD

https://digscholarship.unco.edu/urj/vol9/iss1/2

Significant?
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
No
Yes
No
No
No
No
No
No
No
No
No
No

Adjusted P Value
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
0.1868
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
0.1868
>0.9999
>0.9999
>0.9999
0.0108
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
>0.9999
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ANOVA- Western Blot
As illustrated in Table 3, the comparison of CBD and THC to media (P value = 0.7364)
indicates that there is not any statistical significance. In addition, the P value for all the
concentrations indicates that there is not any statistically significant difference between them.
Table 3: Western blot comparison of CBD and THC treatment to the media.
Significant difference is when the P valve is 0.05
ANOVA
P value
Exact or approximate P value?
P value summary
Do the medians vary signif. (P < 0.05)?
Number of groups
Kruskal-Wallis statistic
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Figure 6: Comparison of the THC and CBD to the media. B. Multiple comparison, t-test of each
group to every other group.
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Discussion
This study focused on the ascertainment of various concentrations of CBD and THC that
influence MCF-7 breast cancer apoptosis. Studies have shown that certain cannabinoids cause
the apoptosis of cancer cells, but only with a certain concentration, which has not been well
documented. Therefore, this study helped determine the exact concentration of CBD and THC
needed to kill MCF-7 breast cancer cells rather than create mass multiplication leading to more
growth of the cancer. An MTT assay and Western blot were the methods used to conduct this
experiment. The previous research states that CBD was more effective at stimulating apoptosis
compared to THC. However, the most effective concentration of CBD varied between the MTT
assay and the Western blot assay. The previous research results were preliminary; however, this
research is a replication with larger sample sizes. This is a better representative of the population,
making the data more accurate and precise.
As illustrated in the MTT Assay, 100 µM is lower in proliferation in both CBD and THC,
which indicates inhibition of the MCF-7 breast cancer cells. The most salient finding is that 100
µM CBD was the most effective concentration in the MTT assay assessment. However, THC
concentration results vary. At a concentration of 100 µM, THC inhibits the cancer growth, but at
10 µM concentration, THC increases proliferation, meaning the drug stimulates a growth in the
MCF-7 breast cancer cell. Visually, the MTT assay illustrated that CBD was more effective
overall than THC; however, T-Test results indicate that there is not any statistically significantly
difference. Blasco-Benito et al. (2018) suggested that the combination of cannabinoids with
estrogen receptor- or HER2-targeted therapies (tamoxifen and lapatinih, respectively) or with
cisplatin produced additive anti-proliferative responses in cell cultures. THC and CBD did not
show any significant difference compared to the control due to the lack of these combinations.
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Takeda et al. (2008) concluded with RT-PCR analysis that there was no detectable expression of
CB receptors in MCF-7 cells, and therefore cannabinoids had no effect on the cells. However,
the presence of CB receptors cause Δ9-THC to inhibit the proliferation of MCF-7 cells.
As illustrated in the Western blot assessment, as the CBD concentrations increase, the
apoptosis decreases in MCF-7 breast cancer cells. In Figure 4, the 0.1 µM CBD concentration
resulted in the most apoptosis compared to all the other CBD concentrations. Western blot
results conflict with the MTT assay; this may be due to fact that there was a larger sample size in
the MTT assay then there was in the Western blot. THC concentration had mixed effects on the
MCF-7 breast cancer cells. Figure 4 also shows that 0.1 µM concentration was most effective for
both CBD and THC.
However, the most effective concentrations of CBD and THC on the MCF-7 breast
cancer cells as assessed by Western blot were different from the MTT assay’s most effective
concentration. Even though Western blot and MTT assay have different values for effective
concentrations, both methods show that there is indeed an apoptosis of MCF-7 breast cancer
cells due to the influence of CBD or THC. However, this effective concentration did not have a
statistically significant difference. The research by Petreocells et al. (1998) indicated that
anandamide works best on the MCF-7 breast cancer cell with concentrations of 5-10 µM, which
works by blocking human breast cancer cell proliferation through CBI-like receptor-mediated
inhibition of endogenous prolactin action at the level of prolactin receptor.
Focusing on the Western blot, THC has the opposite effect at concentrations of 1 µM and
100 µM, indicating that there was no apoptosis among MCF-7 breast cancer cells or perhaps that
proliferation was stimulated. Comparing the information to the MTT assay, 10 µM THC caused
proliferation, but in the Western blot, 1 µM and 100 µM caused proliferation. The proliferation
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occurred in both methods, proving that THC could perhaps stimulate proliferation instead of
inhibiting the MCF-7 breast cancer cells. Sarfaraz et al. (2008) stated that low doses of
cannabinoids cause acceleration of proliferation of the cancer cells instead of inducing apoptosis.
Sarfarz et al. results were supported by THC concentration at 10 µM from MTT assay and 1 µM,
100 µM from Western blot assay.
Statistically, there is no significant difference between CBD and THC from the Western
blot. Furthermore, there is no significant difference among all the concentrations from the
Western blot, but visually there is trend. Even though the statistical data show no significant
difference between the media and the concentration, multiple reports, such as Blasco-Benito et
al. (2018), Sarfaraz et al. (2008), and Velasco et al. (2016), have shown that cannabinoids do
cause anti-proliferation of cancer cells. The lack of statistically significant difference in this
research could be because the sample sizes were not quite large enough.
THC and CBD appeared to be effective on the MCF-7 cancer cells; 100 µM or 0.1 µM
showed inhibition of MCF-7 cancer cells depending on the use of Western blot or MTT assay.
Moving forward, an alternative to the MTT assay could be used, since MTT assay is not
sensitive enough for the time points examined. The next focus will be using Western blot to
narrow down between these two concentrations at which the drug causes inhibition of the
proliferation of breast cancer and testing enough to get a statistically significant difference
between the concentration of CBD and THC to media. Favorable findings may provide an
accessible and affordable cannabinoid-based treatment for patients.
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Conclusions
CBD and THC appeared to be effective at stimulating apoptosis of the MCF-7 breast
cancer cells; however, there were no statistically significant differences. Western blot illustrated
that at 0.1 µM, CBD and THC are the most effective at stimulating inhibition of the MCF-7
human breast cancer cells, while MTT assay illustrated that at 100 µM, CBD and THC are most
effective at stimulating apoptosis of the MCF-7 breast cancer cells. Since Western blot is the
more reliable method, the concentration provided from the Western blot should be examined
further. However, the sample size for the Western blot was small, and larger sample sizes for the
Western blot will therefore be the next focus.
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